Related references
Note: Only part of the references are listed.More than matrix: The multifaceted role of decorin in cancer
David Denis Sofeu Feugaing et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2013)
Decorin A Guardian from the Matrix
Thomas Neill et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice
Xiuli Bi et al.
CARCINOGENESIS (2012)
Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation
Kristin Moreth et al.
CELL CYCLE (2012)
Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation
Liliana Schaefer et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
The galactosaminoglycan-containing decorin and its impact on diseases
Daniela G. Seidler
CURRENT OPINION IN STRUCTURAL BIOLOGY (2012)
Decorin Antagonizes the Angiogenic Network CONCURRENT INHIBITION OF MET, HYPOXIA INDUCIBLE FACTOR 1α, VASCULAR ENDOTHELIAL GROWTH FACTOR A, AND INDUCTION OF THROMBOSPONDIN-1 AND TIMP3
Thomas Neill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Heparanase Enhances the Insulin Receptor Signaling Pathway to Activate Extracellular Signal-regulated Kinase in Multiple Myeloma
Anurag Purushothaman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Insulin and Insulin-like Growth Factor II Differentially Regulate Endocytic Sorting and Stability of Insulin Receptor Isoform A
Alaide Morcavallo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Biology of Small Leucine-rich Proteoglycans in Bone Pathophysiology
Dragana Nikitovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification of Common and Distinctive Mechanisms of Resistance to Different Anti-IGF-IR Agents in Ewing's Sarcoma
Cecilia Garofalo et al.
MOLECULAR ENDOCRINOLOGY (2012)
Targeting heparanase for cancer therapy at the tumor-matrix interface
Ralph D. Sanderson et al.
MATRIX BIOLOGY (2012)
Proline-Rich Tyrosine Kinase 2 (Pyk2) Regulates IGF-I-Induced Cell Motility and Invasion of Urothelial Carcinoma Cells
Marco Genua et al.
PLOS ONE (2012)
Decorin Protein Core Affects the Global Gene Expression Profile of the Tumor Microenvironment in a Triple-Negative Orthotopic Breast Carcinoma Xenograft Model
Simone Buraschi et al.
PLOS ONE (2012)
` The Dermatan Sulfate Proteoglycan Decorin Modulates α2β1 Integrin and the Vimentin Intermediate Filament System during Collagen Synthesis
Oliver Jungmann et al.
PLOS ONE (2012)
The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
Roberta Malaguarnera et al.
JOURNAL OF ONCOLOGY (2012)
Insulin receptor and cancer
Antonino Belfiore et al.
ENDOCRINE-RELATED CANCER (2011)
Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream Signaling
Renato V. Iozzo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Renato V. Iozzo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
The Role for Decorin in Delayed-Type Hypersensitivity
Daniela G. Seidler et al.
JOURNAL OF IMMUNOLOGY (2011)
Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice
Kornelia Baghy et al.
LABORATORY INVESTIGATION (2011)
Decorin Is a Novel VEGFR-2-Binding Antagonist for the Human Extravillous Trophoblast
Gausal A. Khan et al.
MOLECULAR ENDOCRINOLOGY (2011)
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2
Traci R. Lyons et al.
NATURE MEDICINE (2011)
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling
C. Garofalo et al.
ONCOGENE (2011)
Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 and MicroRNA-21
Rosetta Merline et al.
SCIENCE SIGNALING (2011)
The Insulin-Like Growth Factor Receptor I Promotes Motility and Invasion of Bladder Cancer Cells through Akt- and Mitogen-Activated Protein Kinase-Dependent Activation of Paxillin
David Metalli et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
Achilleas D. Theocharis et al.
FEBS JOURNAL (2010)
Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans
Renato V. Iozzo et al.
FEBS JOURNAL (2010)
Decorin Antagonizes Met Receptor Activity and Down-regulates β-Catenin and Myc Levels
Simone Buraschi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The role of small leucine-rich proteoglycans in collagen fibrillogenesis
Sebastian Kalamajski et al.
MATRIX BIOLOGY (2010)
MYC in Oncogenesis and as a Target for Cancer Therapies
Ami Albihn et al.
ADVANCES IN CANCER RESEARCH, VOL 107 (2010)
Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladder
Jenny A. Watson et al.
BJU INTERNATIONAL (2009)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Decorin is a novel antagonistic ligand of the Met receptor
Silvia Goldoni et al.
JOURNAL OF CELL BIOLOGY (2009)
Decorin Suppresses Bone Metastasis in a Breast Cancer Cell Line
Kentaro Araki et al.
ONCOLOGY (2009)
Decorin Suppresses Prostate Tumor Growth through Inhibition of Epidermal Growth Factor and Androgen Receptor Pathways
Yunping Hu et al.
NEOPLASIA (2009)
An antimetastatic role for decorin in breast cancer
Silvia Goldoni et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation
Xiuli Bi et al.
CARCINOGENESIS (2008)
Decorin-Mediated Inhibition of Proliferation and Migration of the Human Trophoblast via Different Tyrosine Kinase Receptors
D. Iacob et al.
ENDOCRINOLOGY (2008)
Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs
Silvia Goldoni et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of α2β1 integrin activity
Lorna R. Fiedler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Grb10/Nedd4-mediated multiubiquitination of the insulin-like growth factor receptor regulates receptor internalization
Giada Monami et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Human microvascular endothelial cells are sensitive to IGF-I but resistant to insulin at the receptor level
G. S. Johansson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Decorin deficiency enhances progressive nephropathy in diabetic mice
Kevin Jon Williams et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis
Claus Ruehland et al.
FEBS JOURNAL (2007)
Endocytosis of the dermatan sulfate proteoglycan decorin utilizes multiple pathways and is modulated by epidermal growth factor receptor signaling
David Denis Sofeu Feugaing et al.
BIOCHIMIE (2007)
Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and mammalian target of rapamycin
Liliana Schaefer et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation
Daniela G. Seidler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development
Guiyun Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro
Anne Vestergard Moller et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
A role for decorin in cutaneous wound healing and angiogenesis
Hannu Jarvelainen et al.
WOUND REPAIR AND REGENERATION (2006)
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
M Sanchez-Carbayo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis
JX Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Decorin, a novel player in the insulin-like growth factor system
E Schönherr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Decorin prevents metastatic spreading of breast cancer
CC Reed et al.
ONCOGENE (2005)
Influence of decorin and biglycan on mechanical properties of multiple tendons in knockout mice
PS Robinson et al.
JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME (2005)
Biologically active decorin is a monomer in solution
S Goldoni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protective niche for Borrelia burgdorferi to evade humoral immunity
FT Liang et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Investigating tendon fascicle structure-function relationships in a transgenic-age mouse model using multiple regression models
PS Robinson et al.
ANNALS OF BIOMEDICAL ENGINEERING (2004)
Decorin deficiency leads to impaired angiogenesis in injured mouse cornea
E Schonherr et al.
JOURNAL OF VASCULAR RESEARCH (2004)
Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model
A Biglari et al.
CANCER GENE THERAPY (2004)
Gene expression in the urinary bladder:: A common carcinoma in situ gene expression signature exists disregarding histopathological classification
L Dyrskjot et al.
CANCER RESEARCH (2004)
Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope
M Santra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin
CC Reed et al.
ONCOGENE (2002)
The role of decorin in collagen fibrillogenesis and skin homeostasis
CC Reed et al.
GLYCOCONJUGATE JOURNAL (2002)
A role for decorin in the structural organization of periodontal ligament
L Häkkinen et al.
LABORATORY INVESTIGATION (2000)
The contradictions of the insulin-like growth factor 1 receptor
R Baserga
ONCOGENE (2000)
An anti-oncogenic role for decorin - Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells
M Santra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Sustained down-regulation of the epidermal growth factor receptor by decorin -: A mechanism for controlling tumor growth in vivo
G Csordás et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Acceleracted publication -: Decorin binds near the C terminus of type I collagen
DR Keene et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
